Possibilities of treating skin lesions in the graft versus host disease using the Pulsavac Plus wound repair system
https://doi.org/10.21682/2311-1267-2020-7-2-112-4
Abstract
This article describes the experience of using the Pulsavac Plus debridement system for atraumatic treatment of the skin in one of the forms of graft versus host diseases after allogeneic hematopoietic stem cell transplantation.
About the Authors
T. Z. Aliev
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia
Russian Federation
Russian Federation
T.Z. Aliev, Pediatric Oncologist Department of Pediatric Bone Marrow and Hematopoietic Stem Cell Transplantation
23 Kashirskoe Shosse, Moscow, 115478, Russia
K. I. Kirgizov
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia
Russian Federation
Russian Federation
Cand. of Sci. (Med.), Deputy Director for Scientific and Educational Work of Research Institute of Pediatric Oncology and Hematology
23 Kashirskoe Shosse, Moscow, 115478, Russia
T. S. Belysheva
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia
Russian Federation
Russian Federation
Dr. of Sci. (Med.), Dermatologist, Leading Researcher at the Scientific Advisory Department
23 Kashirskoe Shosse, Moscow, 115478, Russia
References
1. Zimmer® Pulsavac® Plus. A family of devices for the rehabilitation of the wound surface. Information booklet. [Electronic resource]: http://www.zimmerrussia.ru/content/dam/zimmer-web/documents/ru-RU/pdf/medicalprofessionals/surgicalZimmer_Pulsavac_Plus_Family_BRO_RUS_corr.pdf. (In Russ.)
2. Jagasia M.H., Greinix H.T., Arora M., Williams K.M., Wolff D., Cowen E.W., Palmer J., Weisdorf D., Treister N.S., Cheng G.S., Kerr H., Stratton P., Duarte R.F., McDonald G.B., Inamoto Y., Vigorito A., Arai S., Datiles M.B., Jacobsohn D., Heller T., Kitko C.L., Mitchell S.A., Martin P.J., Shulman H., Wu R.S., Cutler C.S., Vogelsang G.B., Lee S.J., Pavletic S.Z., Flowers M.E. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 2015;21(3):389–401. doi: 10.1016 / j.bbmt.2014.12.001.
3. Skvortsova Yu.V., Novichkova G.A., Maschan A.A. New in the pathogenesis, diagnosis and treatment of the chronic graft versus host reaction after allogeneic HSCT. Voprosy gematologii/onkologii i immunopatologii v pediatrii = Pediatric Hematology/Oncology and Immunopathology 2018;17(2):121–35. (In Russ.)
Review
For citations:
Aliev T.Z., Kirgizov K.I., Belysheva T.S. Possibilities of treating skin lesions in the graft versus host disease using the Pulsavac Plus wound repair system. Russian Journal of Pediatric Hematology and Oncology. 2020;7(2):112-114. (In Russ.) https://doi.org/10.21682/2311-1267-2020-7-2-112-4
Views:
555
Email this article 